Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Enovis (ENOV) Research & Development (2021 - 2025)

Enovis (ENOV) has disclosed Research & Development for 7 consecutive years, with $31.4 million as the latest value for Q4 2025.

  • Quarterly Research & Development rose 30.95% to $31.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $120.3 million through Dec 2025, up 31.8% year-over-year, with the annual reading at $120.3 million for FY2025, 31.8% up from the prior year.
  • Research & Development for Q4 2025 was $31.4 million at Enovis, up from $29.7 million in the prior quarter.
  • The five-year high for Research & Development was $31.4 million in Q4 2025, with the low at $11.0 million in Q3 2021.
  • Average Research & Development over 5 years is $20.3 million, with a median of $18.9 million recorded in 2023.
  • The sharpest move saw Research & Development decreased 3.34% in 2022, then skyrocketed 45.13% in 2025.
  • Over 5 years, Research & Development stood at $15.2 million in 2021, then dropped by 3.34% to $14.7 million in 2022, then rose by 24.41% to $18.3 million in 2023, then soared by 30.74% to $24.0 million in 2024, then skyrocketed by 30.95% to $31.4 million in 2025.
  • According to Business Quant data, Research & Development over the past three periods came in at $31.4 million, $29.7 million, and $30.7 million for Q4 2025, Q4 2025, and Q3 2025 respectively.